Adam Levy
2022 - Mineralys Therapeutics
In 2022, Adam Levy earned a total compensation of $1M as Chief Financial Officer and Secretary at Mineralys Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $190,900 |
|---|---|
| Salary | $334,926 |
| Stock Awards | $483,500 |
| Other | $7,262 |
| Total | $1,016,588 |
Levy received $483.5K in stock awards, accounting for 48% of the total pay in 2022.
Levy also received $190.9K in non-equity incentive plan, $334.9K in salary and $7.3K in other compensation.
Rankings
In 2022, Adam Levy's compensation ranked 2,991st out of 5,736 executives tracked by ExecPay. In other words, Levy earned more than 47.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,991 out of 5,736 | 48th |
Division Manufacturing | 1,679 out of 3,125 | 46th |
Major group Chemicals And Allied Products | 785 out of 1,416 | 45th |
Industry group Drugs | 732 out of 1,317 | 44th |
Industry Pharmaceutical Preparations | 529 out of 963 | 45th |
Source: SEC filing on April 9, 2024.
Levy's colleagues
We found two more compensation records of executives who worked with Adam Levy at Mineralys Therapeutics in 2022.